UM  > 中華醫藥研究院
Analysis of the Current Situation of Antitumor Drug Use in China: A Hospital-Based Perspective
Lai Y.-F.; Lu J.-J.; Hu H.; Wang Y.-T.
2015
Source PublicationTherapeutic Innovation and Regulatory Science
Volume49Issue:1Pages:181
Abstract

Objective: To present a systematic review of the usage of antitumor drugs in Chinese hospitals from 2009 to 2011. Methods: The market data of antitumor drugs was collected from the Menet database that covered 350 Class A tertiary hospitals from 16 major cities in China. The data of antitumor drugs were divided into 3 categories by mechanism action: cytotoxic chemotherapy, molecular targeted therapeutic drugs, and other antitumor drugs. The usage characteristics of each category were analyzed through sales volume and sales value, and the characteristics of main drugs in each category were further analyzed. Results: During 2009-2011, the sales volume and sales value of antitumor drugs used in hospitals had markedly increased in China. Specifically, cytotoxic chemotherapy was the most prevalent category in clinical treatment, with total sales volume shares of 61.93%, 63.90%, and 68.40% during 2009-2011. Its share of total sales value was more than 70% in the same period. The sales volume share of molecular targeted therapeutic drugs was less than 1%, but the sales value share was about 20% in the corresponding period. In addition, plant alkaloids had become the leading subcategory of antitumor drugs in hospitals, which contributed 43.72% of total sales volume and 37% of total sales value in 2011. Antimetabolites still played an important role, with around 20% of sales volume, and monoclonal antibody and small-molecule compounds experienced rapid growth. Conclusions: Plant alkaloids have become the most widely used antitumor drug for clinical medical treatment in China. In the future, monoclonal antibody and small-molecule compounds are expected to have wider usage in China. © The Author(s) 2014.

KeywordAntitumor Drugs China Clinical Treatment Drug Usage Plant Alkaloids
DOI10.1177/2168479014543700
URLView the original
Indexed BySCI
Language英语
WOS Research AreaMedical Informatics ; Pharmacology & Pharmacy
WOS SubjectMedical Informatics ; Pharmacology & Pharmacy
WOS IDWOS:000347965200024
The Source to ArticleScopus
全文获取链接
引用统计
Document TypeJournal article
专题Institute of Chinese Medical Sciences
AffiliationState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau
First Author AffilicationInstitute of Chinese Medical Sciences
推荐引用方式
GB/T 7714
Lai Y.-F.,Lu J.-J.,Hu H.,et al. Analysis of the Current Situation of Antitumor Drug Use in China: A Hospital-Based Perspective[J]. Therapeutic Innovation and Regulatory Science,2015,49(1):181.
APA Lai Y.-F.,Lu J.-J.,Hu H.,&Wang Y.-T..(2015).Analysis of the Current Situation of Antitumor Drug Use in China: A Hospital-Based Perspective.Therapeutic Innovation and Regulatory Science,49(1),181.
MLA Lai Y.-F.,et al."Analysis of the Current Situation of Antitumor Drug Use in China: A Hospital-Based Perspective".Therapeutic Innovation and Regulatory Science 49.1(2015):181.
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
Google Scholar
中相似的文章 Google Scholar
[Lai Y.-F.]的文章
[Lu J.-J.]的文章
[Hu H.]的文章
Baidu academic
中相似的文章 Baidu academic
[Lai Y.-F.]的文章
[Lu J.-J.]的文章
[Hu H.]的文章
Bing Scholar
中相似的文章 Bing Scholar
[Lai Y.-F.]的文章
[Lu J.-J.]的文章
[Hu H.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。